Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3UFN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,233
Award facts
- Contract value 100% obligated
- $51,233.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $51,233.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 23, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. The order, with an ultimate completion date of January 26, 2026, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's supply chain. The company's capability to fulfill this order for the immunosuppressant medication Dupixent reflects its extensive portfolio in delivering specialty pharmaceuticals across multiple therapeutic domains, including biologics and injectable medications. The non-set-aside competitive award underscores the contractor's demonstrated ability to meet federal procurement requirements and pricing standards for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F3UFN?
SPE2DR26F3UFN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F3UFN worth?
The government has obligated $51,233 on SPE2DR26F3UFN.
Is contract SPE2DR26F3UFN an order under another contract?
Yes. SPE2DR26F3UFN is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UFN competed?
The extent of competition for SPE2DR26F3UFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award